Results 51 to 60 of about 3,018 (199)

Sarcoma immunotherapy. [PDF]

open access: yes, 2011
Much of our knowledge regarding cancer immunotherapy has been derived from sarcoma models. However, translation of preclinical findings to bedside success has been limited in this disease, though several intriguing clinical studies hint at the potential ...
Gouw, Launce G   +3 more
core   +2 more sources

Expression of GATA3, p63, E-cadherin and Her2Neu Immunohistochemical Stains in Urothelial Carcinoma and their Relationship with Histological Grading and Prognosis- A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Urinary bladder cancer is the 10th most common cancer worldwide. Cystoscopy and biopsy/Transurethral Resection of Bladder Tumour (TURBT) are the best techniques for diagnosing and staging urinary bladder cancers. Urothelial Carcinomas (UC),
Debarghya Mukherjee   +5 more
doaj   +1 more source

Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma [PDF]

open access: yes, 2011
Version of ...
Afamefuna Nduaguba   +9 more
core   +1 more source

Expression of BRCA1 by immunohistochemistry and its association with ER, PR, Her2neu status in infiltrative ductal carcinoma of breast

open access: yesJournal of Cancer Research and Therapeutics, 2023
ABSTRACTS Background: Breast cancer is a heterogeneous disease, which differs in its clinical behaviors and responses to treatment and outcome. The prognosis of breast cancer depends on histopathological parameters and molecular subtypes.
Princy S, Soman   +2 more
openaire   +2 more sources

Pathological responses and long-term outcome analysis after neoadjuvant chemotheraphy in breast cancer patients from Kuwait over a period of 15 years

open access: yesAnnals of Saudi Medicine, 2013
BACKGROUND AND OBJECTIVES: The attainment of pathological complete response (pCR) after neoadjuvant chemotherapy has been taken as a surrogate marker for disease-free survival and overall survival.
Yamini Krishnan   +4 more
doaj   +1 more source

Expression of HER2/neu in gastric adenocarcinoma and its correlation with serum HER2/neu level and E-cadherin expression

open access: yesIndian Journal of Pathology and Microbiology, 2022
Aim: To assess HER2/neu expressions and correlate with E-cadherin and Serum HER2 level in gastric carcinoma. Method: 31 gastric biopsies and 1 resected specimen were taken in the study with patient details and stained with H and E for histopathological ...
Ishan Pandey   +3 more
doaj   +1 more source

Spectral discrimination of breast pathologies in situ using spatial frequency domain imaging [PDF]

open access: yes, 2013
Introduction: Nationally, 25% to 50% of patients undergoing lumpectomy for local management of breast cancer require a secondary excision because of the persistence of residual tumor.
Barth, Richard J   +9 more
core   +5 more sources

The significance of expression of Her2neu in squamous cell carcinoma of uterine cervix

open access: yesInternational Journal of Reproduction, Contraception, Obstetrics and Gynecology, 2019
Background: Cervical cancer is one of the leading causes of cancer related deaths among females. It arises from precursor lesions i.e. squamous intraepithelial lesions which are closely associated with infection by HPV. The ERBB2 protooncogene encodes for a cellular transmembrane protein (erb-b2) which has tyrosine kinase activity and has been ...
Shakti Kumar Yadav   +3 more
openaire   +2 more sources

Treatment Regimens and Response Rates in Early TNBC: A Review of Real‐World Practice in the Second Decade of the 21st Century

open access: yesThe Breast Journal, Volume 2026, Issue 1, 2026.
Background and Aims Real‐world evidence on the treatment of early triple‐negative breast cancer (TNBC) remains limited. This study provides an overview of neoadjuvant chemotherapy (NACT) regimens used in the 2010s of the 21st century, analyzing patient outcomes and treatment patterns based on real‐world data from a large population‐based cancer ...
Maria Eleni Hatzipanagiotou   +9 more
wiley   +1 more source

“HIPOFRACCIONAMIENTO EN CÁNCER DE MAMA EN PACIENTES MAYORES DE 70 AÑOS DE EDAD EN EL CENTRO ONCOLÓGICO ESTATAL ISSEMyM MARZO 2011 – MARZO 2013” [PDF]

open access: yes, 2014
El cáncer de mama afecta cada vez más la vida de mujeres mayores, sobre todo en países desarrollados. En las ̼últimas tres décadas las mujeres de todos los grupos de edad han experimentado una disminución en la mortalidad secundaria a un diagnóstico más ...
Buendia Lopez, Eliana Cristina
core  

Home - About - Disclaimer - Privacy